In testing the efficacy of this TfR directed cargo delivery into human cancer cells, a negative control cell line which expresses no hTfR on cell membrane is needed for comparison with results obtained from hTfR+ cells to assure this hTfR-targeting specificity. Here, TFRC is linked to cancer.